Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank93
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
2.10
↑ 135% vs avg
Percentile
P93
Near historical high
Streak
1 yr
Consecutive declineElevated
Average
-6.07
Historical baseline
PeriodValueYoY Change
20252.10-87.6%
202416.91+268.2%
2023-10.06-127.8%
2022-4.42+82.5%
2021-25.22-27.0%
2020-19.86-269.2%
2019-5.38-2.7%
2018-5.24+16.6%
2017-6.28-93.6%
2016-3.25-